291 related articles for article (PubMed ID: 19509103)
1. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.
Hsiao HP; Kirschner LS; Bourdeau I; Keil MF; Boikos SA; Verma S; Robinson-White AJ; Nesterova M; Lacroix A; Stratakis CA
J Clin Endocrinol Metab; 2009 Aug; 94(8):2930-7. PubMed ID: 19509103
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
3. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
Assie G; Louiset E; Sturm N; René-Corail F; Groussin L; Bertherat J; Thomas M; Lefebvre H; Feige JJ; Clauser E; Chabre O; Cherradi N
J Clin Endocrinol Metab; 2010 Oct; 95(10):E253-62. PubMed ID: 20660048
[TBL] [Abstract][Full Text] [Related]
5. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.
Groussin L; Perlemoine K; Contesse V; Lefebvre H; Tabarin A; Thieblot P; Schlienger JL; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 May; 87(5):1980-5. PubMed ID: 11994328
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
Mazzuco TL; Thomas M; Martinie M; Cherradi N; Sturm N; Feige JJ; Chabre O
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1452-62. PubMed ID: 18209887
[TBL] [Abstract][Full Text] [Related]
7. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).
Stratakis CA
Endocr Dev; 2008; 13():117-132. PubMed ID: 18493137
[TBL] [Abstract][Full Text] [Related]
8. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators.
Bourdeau I; Antonini SR; Lacroix A; Kirschner LS; Matyakhina L; Lorang D; Libutti SK; Stratakis CA
Oncogene; 2004 Feb; 23(8):1575-85. PubMed ID: 14767469
[TBL] [Abstract][Full Text] [Related]
9. Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene.
Yamakita N; Murai T; Ito Y; Miura K; Ikeda T; Miyamoto K; Onami S; Yoshida T
Intern Med; 1997 Aug; 36(8):536-42. PubMed ID: 9260769
[TBL] [Abstract][Full Text] [Related]
10. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
[TBL] [Abstract][Full Text] [Related]
11. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia treated with mitotane.
Nagai M; Narita I; Omori K; Komura S; Arakawa M
Intern Med; 1999 Dec; 38(12):969-73. PubMed ID: 10628936
[TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene.
Fragoso MC; Domenice S; Latronico AC; Martin RM; Pereira MA; Zerbini MC; Lucon AM; Mendonca BB
J Clin Endocrinol Metab; 2003 May; 88(5):2147-51. PubMed ID: 12727968
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease.
Bourdeau I; Stratakis CA
Ann N Y Acad Sci; 2002 Jun; 968():240-55. PubMed ID: 12119280
[TBL] [Abstract][Full Text] [Related]
14. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
Hofland J; Hofland LJ; van Koetsveld PM; Steenbergen J; de Herder WW; van Eijck CH; de Krijger RR; van Nederveen FH; van Aken MO; de Groot JW; Links TP; de Jong FH; Feelders RA
Orphanet J Rare Dis; 2013 Sep; 8():142. PubMed ID: 24034279
[TBL] [Abstract][Full Text] [Related]
15. Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.
Oki K; Yamane K; Nakanishi S; Nakashima R; Jitsuiki K; Kohno N
Endocrine; 2009 Dec; 36(3):372-6. PubMed ID: 19813002
[TBL] [Abstract][Full Text] [Related]
16. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Mune T; Murase H; Yamakita N; Fukuda T; Murayama M; Miura A; Suwa T; Hanafusa J; Daido H; Morita H; Yasuda K
J Clin Endocrinol Metab; 2002 Dec; 87(12):5706-13. PubMed ID: 12466375
[TBL] [Abstract][Full Text] [Related]
17. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors.
Vezzosi D; Cartier D; Régnier C; Otal P; Bennet A; Parmentier F; Plantavid M; Lacroix A; Lefebvre H; Caron P
Eur J Endocrinol; 2007 Jan; 156(1):21-31. PubMed ID: 17218722
[TBL] [Abstract][Full Text] [Related]
18. [ACTH-independent bilateral adrenocortical macronodular hyperplasia (AIMAH): report of a case].
Nakano M; Tada K; Takahashi Y; Deguchi T; Kuriyama M; Ban Y; Kawada Y; Hanafusa J; Morita H; Yasuda K
Hinyokika Kiyo; 1995 Jul; 41(7):529-32. PubMed ID: 7668183
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature.
Aiba M; Hirayama A; Iri H; Ito Y; Fujimoto Y; Mabuchi G; Murai M; Tazaki H; Maruyama H; Saruta T
Am J Clin Pathol; 1991 Sep; 96(3):334-40. PubMed ID: 1652202
[TBL] [Abstract][Full Text] [Related]
20. A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids.
Hayashi Y; Takeda Y; Kaneko K; Koyama H; Aiba M; Ikeda U; Shimada K
Endocr J; 1998 Aug; 45(4):485-91. PubMed ID: 9881897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
